High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study

Atherosclerosis

Volumn 247, Issue , 2016, Pages 135-141

  Oemrawsingh, Rohit M ^a,b   Cheng, Jin M ^a   García García, Héctor M ^c,d   Kardys, Isabella ^a   van Schaik, Ron H N ^e   Regar, Evelyn ^a   van Geuns, Robert Jan ^a   Serruys, Patrick W ^a   Boersma, Eric ^a   Akkerhuis, K Martijn ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b INTERUNIVERSITY CARDIOLOGY INSTITUTE OF THE NETHERLANDS   (Netherlands)

^c CARDIALYSIS   (Netherlands)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Intravascular ultrasound; Stable coronary artery disease; Thin cap fibroatheroma; Troponin

Indexed keywords

HIGH SENSITIVITY TROPONIN T; TROPONIN T; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TNNT2 PROTEIN, HUMAN;

ADULT; ADVERSE OUTCOME; ANGIOCARDIOGRAPHY; ARTICLE; CONCENTRATION (PARAMETERS); CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INTRAVENOUS UROGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STABLE ANGINA PECTORIS; AGED; ATHEROSCLEROTIC PLAQUE; BLOOD; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; ODDS RATIO; PHENOTYPE; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; RUPTURE; STATISTICAL MODEL; UPREGULATION;

AGED; BIOMARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; ODDS RATIO; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; RUPTURE, SPONTANEOUS; TROPONIN T; ULTRASONOGRAPHY, INTERVENTIONAL; UP-REGULATION;

EID: 84958980216     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.02.012     Document Type: Article

References (28)

1. Roffi M., Patrono C., Collet J.-P., Mueller C., Valgimigli M., et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2015, Authors/Task Force Members. 10.1093/eurheartj/ehv320.
2. Hsieh B.P.C., Rogers A.M., Na B., Wu A.H.B., Schiller N.B., Whooley M.A. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul Study. Am. Heart J. 2009, 158:673-679. 10.1016/j.ahj.2009.07.021.
3. Beatty A.L., Ku I.A., Christenson R.H., DeFilippi C.R., Schiller N.B., Whooley M.A. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. JAMA Intern. Med. 2013, 173:763-769. 10.1001/jamainternmed.2013.116.
4. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., et al. A sensitive cardiac Troponin T assay in stable coronary artery disease. N. Engl. J. Med. 2009, 361:2538-2547. 10.1056/NEJMoa0805299.
5. Everett B.M., Brooks M.M., Vlachos H.E.A., Chaitman B.R., Frye R.L., Bhatt D.L. Troponin and cardiac events in stable ischemic heart disease and diabetes. N. Engl. J. Med. 2015, 373:610-620. 10.1056/NEJMoa1415921.
6. Koenig W., Breitling L.P., Hahmann H., Wüsten B., Brenner H., Rothenbacher D. Cardiac Troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin. Chem. 2012, 58:1215-1224. 10.1373/clinchem.2012.183319.
7. Melloni C., Roe M.T. Cardiac troponin and risk stratification in ischemic heart disease. N. Engl. J. Med. 2015, 373:672-674. 10.1056/NEJMe1506298.
8. de Boer S.P.M., Cheng J.M., Garcia-Garcia H.M., Oemrawsingh R.M., van Geuns R.-J., Regar E., et al. Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study. EuroInterv. J. Eur. Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol. 2014, 10:953-960. 10.4244/EIJY13M08_01.
9. Cheng J.M., Garcia-Garcia H.M., de Boer S.P.M., Kardys I., Heo J.H., Akkerhuis K.M., et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur. Heart J. 2014, 35:639-647. 10.1093/eurheartj/eht484.
10. Giannitsis E., Katus H.A. Cardiac troponin level elevations not related to acute coronary syndromes. Nat. Rev. Cardiol. 2013, 10:623-634. 10.1038/nrcardio.2013.129.
11. Giannitsis E., Roth H.J., Leithauser R.M., Scherhag J., Beneke R., Katus H.A. New highly sensitivity assay used to measure cardiac Troponin T concentration changes during a continuous 216-km marathon. Clin. Chem. 2009, 55:590-592. 10.1373/clinchem.2008.116566.
12. García-García H.M., Mintz G.S., Lerman A., Vince D.G., Margolis M.P., van Es G.-A., et al. Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroInterv. J. Eur. Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol. 2009, 5:177-189.
13. Rodriguez-Granillo G.A., García-García H.M., Mc Fadden E.P., Valgimigli M., Aoki J., de Feyter P., et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J. Am. Coll. Cardiol. 2005, 46:2038-2042. 10.1016/j.jacc.2005.07.064.
14. Peduzzi P., Concato J., Feinstein A.R., Holford T.R. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J. Clin. Epidemiol. 1995, 48:1503-1510.
15. Rassen J.A., Glynn R.J., Brookhart M.A., Schneeweiss S. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am. J. Epidemiol. 2011, 173:1404-1413. 10.1093/aje/kwr001.
16. de Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA J. Am. Med. Assoc. 2010, 304:2503-2512. 10.1001/jama.2010.1768.
17. Stone G.W., Maehara A., Lansky A.J., de Bruyne B., Cristea E., Mintz G.S., et al. A prospective natural-history study of coronary atherosclerosis. N. Engl. J. Med. 2011, 364:226-235. 10.1056/NEJMoa1002358.
18. Calvert P.A., Obaid D.R., O'Sullivan M., Shapiro L.M., McNab D., Densem C.G., et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in vulnerable atherosclerosis) Study. JACC Cardiovasc. Imaging 2011, 4:894-901. 10.1016/j.jcmg.2011.05.005.
19. Korosoglou G., Lehrke S., Mueller D., Hosch W., Kauczor H.-U., Humpert P.M., et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart Br. Card. Soc. 2011, 97:823-831. 10.1136/hrt.2010.193201.
20. Ahmed W., Schlett C.L., Uthamalingam S., Truong Q.A., Koenig W., Rogers I.S., et al. Single resting hsTnT level predicts abnormal myocardial stress test in acute chest pain patients with normal initial standard troponin. JACC Cardiovasc. Imaging 2013, 6:72-82. 10.1016/j.jcmg.2012.08.014.
21. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med. 2013, 368:2004-2013. 10.1056/NEJMra1216063.
22. Newby D.E. Triggering of acute myocardial infarction: beyond the vulnerable plaque. Heart Br. Card. Soc. 2010, 96:1247-1251. 10.1136/hrt.2009.175141.
23. Puri R., Nissen S.E., Shao M., Ballantyne C.M., Barter P.J., Chapman M.J., et al. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. Eur. Heart J. 2013, 34:3182-3190. 10.1093/eurheartj/eht260.
24. Mann J., Davies M.J. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart Br. Card. Soc. 1999, 82:265-268.
25. Burke A.P., Kolodgie F.D., Farb A., Weber D.K., Malcom G.T., Smialek J., et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001, 103:934-940.
26. Korley F.K., George R.T., Jaffe A.S., Rothman R.E., Sokoll L.J., Fernandez C., et al. Low high-sensitivity troponin I and zero coronary artery calcium score identifies coronary CT angiography candidates in whom further testing could be avoided. Acad. Radiol. 2015, 22:1060-1067. 10.1016/j.acra.2015.04.007.
27. Brener S.J., Topol E.J. Troponin, embolization and restoration of microvascular integrity. Eur. Heart J. 2000, 21:1117-1119. 10.1053/euhj.2000.2119.
28. Nair A., Margolis M.P., Kuban B.D., Vince D.G. Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroInterv. J. Eur. Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol. 2007, 3:113-120.